Ameriprise Financial Inc Regeneron Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 366,759 shares of REGN stock, worth $247 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
366,759
Previous 374,878 2.17%
Holding current value
$247 Million
Previous $394 Million 2.15%
% of portfolio
0.1%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $8.31 Million - $9.76 Million
-8,119 Reduced 2.17%
366,759 $386 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $37.4 Million - $45.3 Million
42,333 Added 12.73%
374,878 $394 Million
Q1 2024

May 15, 2024
SELL
$902.69 - $993.35 $2.98 Million - $3.28 Million
-3,306 Reduced 0.98%
332,545 $320 Million
Q4 2023

Feb 14, 2024
SELL
$775.18 - $881.7 $23.1 Million - $26.3 Million
-29,823 Reduced 8.16%
335,851 $295 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $7.52 Million - $9.16 Million
-10,854 Reduced 2.88%
365,674 $301 Million
Q2 2023

Aug 14, 2023
BUY
$700.03 - $830.35 $13 Million - $15.4 Million
18,580 Added 5.19%
376,528 $271 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $15.4 Million - $18.7 Million
22,584 Added 6.73%
357,948 $294 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $28.1 Million - $30.6 Million
39,864 Added 13.49%
335,364 $242 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $7.42 Million - $9.37 Million
-12,936 Reduced 4.19%
295,500 $204 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $49.6 Million - $66.8 Million
-90,395 Reduced 22.66%
308,436 $182 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $4.86 Million - $5.7 Million
-8,165 Reduced 2.01%
398,831 $278 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $14.3 Million - $17.7 Million
26,327 Added 6.92%
406,996 $257 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $17.6 Million - $20.9 Million
-30,628 Reduced 7.45%
380,669 $230 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $59.9 Million - $70.8 Million
126,731 Added 44.53%
411,297 $230 Million
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $5.24 Million - $6.43 Million
11,724 Added 4.3%
284,566 $135 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $1.8 Million - $2.29 Million
-3,764 Reduced 1.36%
272,842 $132 Million
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $2.29 Million - $2.77 Million
4,209 Added 1.55%
276,606 $155 Million
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $8.24 Million - $10.8 Million
-16,695 Reduced 5.77%
272,397 $170 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $9.15 Million - $13.5 Million
-27,220 Reduced 8.61%
289,092 $141 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $173,250 - $237,954
632 Added 0.2%
316,312 $119 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $7.31 Million - $8.51 Million
26,733 Added 9.25%
315,680 $87.6 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $958,120 - $1.33 Million
3,198 Added 1.12%
288,947 $90.4 Million
Q1 2019

May 15, 2019
SELL
$372.08 - $439.57 $4.67 Million - $5.52 Million
-12,556 Reduced 4.21%
285,749 $117 Million
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $378,804 - $454,629
1,128 Added 0.38%
298,305 $111 Million
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $6.44 Million - $7.49 Million
-18,346 Reduced 5.81%
297,177 $120 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $10.4 Million - $12.7 Million
36,669 Added 13.15%
315,523 $109 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $9.74 Million - $12.1 Million
30,853 Added 12.44%
278,854 $96 Million
Q4 2017

Feb 12, 2018
BUY
$358.63 - $469.95 $10.4 Million - $13.6 Million
28,984 Added 13.23%
248,001 $93.2 Million
Q3 2017

Nov 07, 2017
BUY
$431.38 - $504.0 $94.5 Million - $110 Million
219,017
219,017 $97.9 Million

Others Institutions Holding REGN

# of Institutions
1,500
Shares Held
83M
Call Options Held
1.22M
Put Options Held
1.5M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email